‘Our digital and physical team members, across all subsidiaries, continue to deliver consistent reliable revenue growth as we scale-up our new digital platform.’
Gerry Brandon, CEO Integumen
Lab-grown, human skin, for testing cosmetic and pharma products for dandruff, acne, fungal and bacterial infection.
Innovenn Skin Science
Labskin Certification of products, and training of Lab technicians. Virtual Lab services for cosmetic, skincare and pharma companies.
Skincare products derived from 5 natural super-ingredient plant extracts for men to reduce the signs of aging.
Visual diagnostic wound dressing that changes colour to indicate infection or improvement of the wound under the dressing.
The design and fabrication of smart materials for studying, directing and mimicking biology.
Omega 3 from Algae
Major health benefits, an alternative production to extraction from declining global fish stocks.
Solution to dumping 8 million tonnes of waste plastic in the oceans each year. Alternative biodegradable plastic solution.
Low-cost, solvent-free, commercial scale production of Omega-3 oils from micro-algae and CBD oils from hemp.
Commercial License Partners of the Algzym Technology platform for bio-based oils, Omega 3, CBD and bio-plastic ingredients.
CEO of Cellulac. Founder and CEO of Alltracel Pharmaceuticals and Managing Partner at Farmabrand PE, Fellow of the Ryan Academy of Entrepreneurs
Former Operations Director at Campbell Bewley Group before becoming Chief of Operations at Alltracel Pharmaceuticals Member of the Institute of Chartered Accountants
Founder of Rinocloud. Senior Executive in high growth software (SaaS) systems for Financial and Government Services, Global Biotech and Domestic Energy & Water Utilities
Former head of new business development at 8 West Consulting (clients including Estee Lauder, Avon, Anthem Inc.), experienced VP of international sales with partners such as Accenture, Siemens, SAP, Dell and Sony.
Former Group Information Officer at the Australian Medical Association. Cross-platform software expertise in medical and science applications across enterprise, cloud computing, artificial intelligence and IT operations.
James is an open-source developer and distributed systems advocate with a keen interest in engagement/collaboration platforms. A specialist in open-source technologies and advanced software architecture.
Talented results-driven digital marketing strategist with experience across a range of design led disciplines including UI/UX design, branding and web development. 15 years of experience in technology and design.
Dr. David Callero
David joined the Integumen team as part of Labskin.
Alex joined the Integumen team as part of Labskin.
As at 20 December 2019, shareholders holding more than 3% of the share capital of Integumen were:
Helium Rising Stars – 79,000,391 shares (7.37% of existing share capital)
Cellulac plc – 38,205,127 (3.56% of existing share capital)